Pathstone Holdings
LLY icon

Pathstone Holdings’s Eli Lilly LLY Stock Holding History

Pathstone Holdings’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143M Buy
118,903
+3,414
+3% +$3.49M 0.42% 41
2026
Q1 		$106M Buy
115,489
+1,993
+2% +$2.02M 0.42% 39
2025
Q4 		$122M Buy
113,496
+18,962
+20% +$18.1M 0.47% 35
2025
Q3 		$72.1M Sell
94,534
-1,845
-2% -$1.37M 0.28% 57
2025
Q2 		$75.1M Sell
96,379
-3,744
-4% -$2.91M 0.3% 56
2025
Q1 		$82.7M Buy
100,123
+4,636
+5% +$3.86M 0.36% 46
2024
Q4 		$73.7M Sell
95,487
-1,585
-2% -$1.31M 0.33% 53
2024
Q3 		$86M Sell
97,072
-3,102
-3% -$2.79M 0.38% 42
2024
Q2 		$90.7M Buy
100,174
+1,881
+2% +$1.5M 0.41% 38
2024
Q1 		$76.5M Buy
98,293
+110
+0.1% +$78.3K 0.36% 45
2023
Q4 		$57.6M Buy
+98,183
New +$57.3M 0.31% 55

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pathstone Holdings's LLY Position: Q2 2026 in Review

Pathstone Holdings increased its Eli Lilly (LLY) stake by 3% in Q2 2026, buying an estimated $3.49M and bringing the position to 118,903 shares worth $143M. The position accounts for 0.42% of the portfolio, ranked #41.

Pathstone Holdings first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pathstone Holdings held 118,903 shares of Eli Lilly worth $143M as of Q2 2026.
  • Pathstone Holdings bought 3,414 Eli Lilly shares in Q2 2026, an estimated $3.49M.
  • Eli Lilly made up 0.42% of Pathstone Holdings's portfolio in Q2 2026, its #41 holding.
  • Pathstone Holdings first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.